SCHEMBL12745953

SCHEMBL12745953

[C-]#[N+]c1cc(F)cc(C2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30518 0.70 PGR (0.40) —
SCHEMBL19626190 0.69 — —
SCHEMBL22498139 0.69 LPL (0.44) —
SCHEMBL23914190 0.66 — —
SCHEMBL10243144 0.64 ACHE (0.36) —
SCHEMBL9946146 0.64 ALDH1A1 (0.32) —
SCHEMBL9946145 0.64 — —
SCHEMBL17863581 0.62 MAPK1 (0.37) —
SCHEMBL22820750 0.60 — —
SCHEMBL12341956 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160272600-A1 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, LLC 2016-09-22 — — US disclosed
US-9212153-B2 Inhibitors of beta-secretase VITAE PHARMACEUTICALS, INC. (US) 2015-12-15 — — US disclosed
US-20140200223-A1 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. 2014-07-17 — — US disclosed
US-8633212-B2 Inhibitors of beta-secretase VITAE PHARMACEUTICALS, INC. (US) 2014-01-21 — — US disclosed
US-20110071126-A1 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. 2011-03-24 — — US disclosed
Send feedback